Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
HER2 in Bladder Cancer: Breaking Through the Molecular Frontier
Vadim S. Koshkin, MD
Advancing Myasthenia Gravis (MG) Treatment Through Guideline Updates and Emerging Therapies
October 30, 2025
San Francisco, California
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Kendall Moseley, MD
Kenneth G. Saag, MD
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Nicholas J. Silvestri, MD
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD
Lea Azour, MD
Ashwin Basavaraj, MD
What’s New In Glaucoma?
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Hans Katzberg, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
First Results From Cohort 4 of the SunRISe-1 Trial
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
Ocular to Generalized MG: How and Why the Disease Evolves
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Neal Shore, MD, FACS
Sarah Psutka, MD, MS
Diagnostic Advances in gMG: Effective Tools and Techniques
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
What’s New in Glaucoma Therapy?
What’s New in Subconjunctival MIBS
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.